Bioventus (BVS) Operating Expenses (2020 - 2026)
Bioventus' (BVS) quarterly Operating Expenses came in at $81.2 million in Q1 2026, up 6.19% YoY from $76.5 million in Q1 2025, and down 5.27% on a QoQ basis from $85.8 million in Q4 2025.
Bioventus (BVS) Operating Expenses (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Operating Expenses data on file, last reported at $81.2 million in Q1 2026.
- Quarterly Operating Expenses rose 6.19% year-over-year to $81.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $330.9 million (down 6.22% YoY) and the FY2025 annual result came in at $328.4 million, down 8.2% from the prior year.
- Operating Expenses eased to $81.2 million in Q1 2026, from $85.8 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $100.9 million in Q2 2024 to a low of $72.8 million in Q3 2023.
- A 5-year average of $85.1 million and a median of $84.1 million in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses surged 162.76% — and 2023, when it retreated 18.69%.
- Tracing BVS's Operating Expenses over 5 years: stood at $88.0 million in 2022, then declined by 7.33% to $81.5 million in 2023, then grew by 10.48% to $90.1 million in 2024, then declined by 4.8% to $85.8 million in 2025, then decreased by 5.27% to $81.2 million in 2026.
- The last three Operating Expenses figures came in at $81.2 million (Q1 2026), $85.8 million (Q4 2025), and $81.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Bioventus | 982.75 Mn | 953.29 Mn | 105.67 Mn | 85.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 85.50 Mn |
| Mar 28, 2026 | 81.25 Mn |
| Dec 31, 2025 | 85.76 Mn |
| Sep 27, 2025 | 81.58 Mn |
| Jun 28, 2025 | 82.28 Mn |
| Mar 29, 2025 | 76.51 Mn |
| Dec 31, 2024 | 90.09 Mn |
| Sep 28, 2024 | 85.33 Mn |
| Jun 29, 2024 | 100.88 Mn |
| Mar 30, 2024 | 81.40 Mn |
| Dec 31, 2023 | 81.55 Mn |
| Sep 30, 2023 | 72.81 Mn |
| Jul 1, 2023 | 78.86 Mn |
| Apr 1, 2023 | 84.95 Mn |
| Dec 31, 2022 | 88.00 Mn |
| Oct 1, 2022 | 84.14 Mn |
| Jul 2, 2022 | 96.99 Mn |
| Apr 2, 2022 | 93.63 Mn |
| Dec 31, 2021 | 88.67 Mn |
| Oct 2, 2021 | 77.59 Mn |